Migraine without aura
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Volunteers of both sexes aged between 18 and 90 years; with more than 15 migraine days per month; using migraine prophylaxis medication in the last three months
Exclusion criteria
Exclusion criteria: Patients under 18 years of age; pregnant women; epileptics; patients with sequelae of acute or subacute stroke; patients who abuse analgesic medications for headaches; patients with catamenial headache; patients with less than 15 days of pain per month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: A reduction in the number of days with pain is expected 30 days after the intervention is completed, adjusted for baseline;Outcome finding 1 showed a significant reduction to 9.78 ± 7.12 days per month compared to the baseline of 16 days of pain per month (median 7.00), representing an absolute decrease of 6.22 days and a percentage reduction of 38.9%. Data were collected 30 days after the completion of treatment through the completion of a migraine diary | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome a positive impact on the quality of life of patients treated with photobiomodulation was observed; this improvement was seen in both the active and control groups, with a trend towards superiority in the active group, as assessed by the SF-36 (Short Form Health Questionnaire) with 36 items | — |
Countries
Brazil
Contacts
Município Do Cabo de Santo Agostinho